Ab interno canaloplasty combined with trabecular bypass stenting in eyes with primary open-angle glaucoma

References

• Pillunat LE, Erb C, Junemann AG, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol. 2017;11:1583–1600. doi:10.2147/OPTH.S135316
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96–104. doi:10.1097/ICU.0b013e32834ff1e7
   PubMed Web of Science ®Google Scholar
• Feehan M, Munger MA, Cooper DK, et al. Adherence to glaucoma medications over 12 months in two US community pharmacy chains. J Clin Med. 2016;5. doi:10.3390/jcm5090079
   Web of Science ®Google Scholar
• Kashiwagi K, Matsubara M. Reduction in ocular hypotensive eyedrops by ab interno trabeculotomy improves not only ocular surface condition but also quality of vision. J Ophthalmol. 2018;2018:8165476. doi:10.1155/2018/8165476
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbe A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312–334. doi:10.1016/j.preteyeres.2010.03.001
   PubMed Web of Science ®Google Scholar
• Rosin LM, Bell NP. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol. 2013;7:2131–2135. doi:10.2147/OPTH.S41358
   PubMedGoogle Scholar
• Prevent Blindness. Glaucoma costs reach $5.8 billion annually. December 16, 2013. Available from: https://www.preventblindness.org/glaucoma-costs-reach-5-point-8-billion-annually. Accessed February 6, 2019.
   Google Scholar
• Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189–206. doi:10.2147/OPTH.S80490
   PubMed Web of Science ®Google Scholar
• Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery. Ophthalmology. 2015;122(9):1795–1801. doi:10.1016/j.ophtha.2015.02.029
   Web of Science ®Google Scholar
• Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-based cataract surgery: population health outcomes study of more than 21,000 cases in the United States. Ophthalmology. 2016;123:723–728. doi:10.1016/j.ophtha.2015.12.020
   Web of Science ®Google Scholar
• Vinod K, Gedde SJ. Clinical investigation of new glaucoma procedures. Curr Opin Ophthalmol. 2017;28:187–193. doi:10.1097/ICU.0000000000000336
   PubMed Web of Science ®Google Scholar
• Koerber N. Canaloplasty-A new approach to nonpenetrating glaucoma surgery. Tech Ophthalmol. 2007;5:102–106. doi:10.1097/ITO.0b013e3181565083
   Google Scholar
• Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118:1466–1480. doi:10.1016/j.ophtha.2011.03.028
   PubMed Web of Science ®Google Scholar
• Ondrejka S, Körber N. 360°ab-interno Schlemm’s canal viscodilation in primary open-angle glaucoma. Clin Ophthalmol. 2019;13:1235–1246. doi:10.2147/OPTH.S203917
   Web of Science ®Google Scholar
• Craven ER, Katz LJ, Wells JM, Giamporcaro JE; iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339–1345. doi:10.1016/j.jcrs.2012.03.025
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Chang DF, Marquis R, et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract. The HORIZON study. Ophthalmology. 2019;126:29–37. doi:10.1016/j.ophtha.2018.05.012
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of iStent inject trabecular micro-bypass in primary open-angle glaucoma and cataract. Two-year results. Ophthalmology. 2019;126:811–821.doi:10.1016/j.ophtha.2019.03.006
   Web of Science ®Google Scholar
• Gallardo MJ, Supnet RA, Ahmed IIK. Circumferential viscodilation of Schlemm’s canal for open-angle glaucoma: ab-interno vs ab-externo canaloplasty with tensioning suture. Clin Ophthalmol. 2018;12:2493–2498. doi:10.2147/OPTH.S178962
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/s0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112:1446–1454. doi:10.1001/archopht.1994.01090230060021
   PubMed Web of Science ®Google Scholar
• Vold S, Ahmed IIK, Craven ER, et al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology. 2016;123:2103–2112. doi:10.1016/j.ophtha.2016.06.032
   PubMed Web of Science ®Google Scholar
• Le K, Saheb H. iStent trabecular micro-bypass stent for open-angle glaucoma. Clin Ophthalmol. 2014;8:1937–1945. doi:10.2147/OPTH.S45920
   PubMedGoogle Scholar
• Craven ER. Trabecular micro-bypass shunt (iStent): basic science, clinical, and future. Middle East Afr J Ophthalmol. 2015;22(1):30–37. doi:10.4103/0974-9233.148346
   Google Scholar
• Fernandez-Barrientos Y, Garcia-Feijoo J, Martinez-de-la-Casa JM, Pablo LE, Fernandez-Perez C, Garcia-Sanchez J. Fluorophotometric study of the effect of the Glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci. 2010;51(7):3327–3332. doi:10.1167/iovs.09-3972
   PubMed Web of Science ®Google Scholar
• Camras LJ, Yuan F, Fan S, et al. A novel Schlemm’s canal scaffold increases outflow facility in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2012;53:6115–6121. doi:10.1167/iovs.12-9570
   PubMed Web of Science ®Google Scholar
• Körber N. Ab interno canaloplasty for the treatment of glaucoma: a case series study. Spektrum Augenheilkd. 2018;32:223–227. doi:10.1007/s00717-018-0416-7
   Web of Science ®Google Scholar
• Fea AM, Rekas M, Au L. Evaluation of a Schlemm canal scaffold microstent combined with phacoemulsification in routine clinical practice: two-year multicenter study. J Cataract Refract Surg. 2017;43:886–891. doi:10.1016/j.jcrs.2017.04.039
   Web of Science ®Google Scholar
• Gandolfi SA, Ungaro N, Ghirardini S, Tardini MG, Mora P. Comparison of surgical outcomes between canaloplasty and Schlemm’s canal scaffold at 24 Months’ follow-up. J Ophthalmol. 2016;2016:2410469. doi:10.1155/2016/3410469
   Web of Science ®Google Scholar
• Khaimi MA. Canaloplasty: a minimally invasive and maximally effective glaucoma treatment. J Ophthalmol. 2015;2015:485065. doi:10.1155/2015/485065
   PubMed Web of Science ®Google Scholar